RU2467335C2 - Моноклональные антитела против аннексина а3 для обнаружения карциномы простаты - Google Patents

Моноклональные антитела против аннексина а3 для обнаружения карциномы простаты Download PDF

Info

Publication number
RU2467335C2
RU2467335C2 RU2008152009/15A RU2008152009A RU2467335C2 RU 2467335 C2 RU2467335 C2 RU 2467335C2 RU 2008152009/15 A RU2008152009/15 A RU 2008152009/15A RU 2008152009 A RU2008152009 A RU 2008152009A RU 2467335 C2 RU2467335 C2 RU 2467335C2
Authority
RU
Russia
Prior art keywords
annexin
tgc
antibody
dsm
anxa3
Prior art date
Application number
RU2008152009/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2008152009A (ru
Inventor
Андре ШРАТТЕНХОЛЬЦ (DE)
Андре ШРАТТЕНХОЛЬЦ
Original Assignee
Протеосис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Протеосис Аг filed Critical Протеосис Аг
Publication of RU2008152009A publication Critical patent/RU2008152009A/ru
Application granted granted Critical
Publication of RU2467335C2 publication Critical patent/RU2467335C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2008152009/15A 2006-06-09 2007-06-11 Моноклональные антитела против аннексина а3 для обнаружения карциномы простаты RU2467335C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81208906P 2006-06-09 2006-06-09
US60/812,089 2006-06-09
US85948906P 2006-11-17 2006-11-17
US60/859,489 2006-11-17

Publications (2)

Publication Number Publication Date
RU2008152009A RU2008152009A (ru) 2010-07-20
RU2467335C2 true RU2467335C2 (ru) 2012-11-20

Family

ID=38653814

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008152009/15A RU2467335C2 (ru) 2006-06-09 2007-06-11 Моноклональные антитела против аннексина а3 для обнаружения карциномы простаты

Country Status (13)

Country Link
US (1) US8012697B2 (https=)
EP (1) EP2024748B1 (https=)
JP (1) JP2009540278A (https=)
KR (1) KR20090023372A (https=)
AU (1) AU2007256377B2 (https=)
CA (1) CA2654330A1 (https=)
DE (1) DE07725949T1 (https=)
DK (1) DK2024748T3 (https=)
ES (1) ES2396730T3 (https=)
PL (1) PL2024748T3 (https=)
PT (1) PT2024748E (https=)
RU (1) RU2467335C2 (https=)
WO (1) WO2007141043A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
EP2344544A2 (en) * 2008-09-26 2011-07-20 ProteoSys AG Novel antibodies recognizing native annexin a3
FR2968767B1 (fr) 2010-12-08 2012-12-21 Biomerieux Sa Procede et coffret pour le diagnostic in vitro du cancer de la prostate
WO2013076222A1 (en) 2011-11-23 2013-05-30 Proteosys Ag Differential annexin a3 measurements of serum and blood derivatives or fractions thereof for the diagnosis of prostate cancer
FR2991777B1 (fr) 2012-06-07 2015-08-21 Biomerieux Sa Procede de detection et/ou de dosage de l'annexine a3 d'un mammifere dans le sang ou au moins un de ses derives
WO2015035941A1 (en) * 2013-09-12 2015-03-19 The University Of Hong Kong Use of annexin a3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
US9470677B2 (en) 2013-11-28 2016-10-18 Samsung Electronics Co., Ltd. Cell with surface coated with ANXA1 and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4104910C3 (de) 1991-02-18 2000-02-24 Schloemann Siemag Ag Stahlnachbehandlungsanlage
US5136855A (en) 1991-03-05 1992-08-11 Ontario Hydro Heat pump having an accumulator with refrigerant level sensor
WO2003009814A2 (en) * 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
DE10217254A1 (de) 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
JP5068543B2 (ja) * 2004-02-16 2012-11-07 プロテオジス アクチェンゲゼルシャフト がんに関する診断マーカー
EP1724585A1 (en) * 2005-05-21 2006-11-22 ProteoSys AG Annexin for cancer risk assessment
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Diakonova M., et al., "Localization of five annexins in J774 macrophages and on isolated phagosomes." J Cell Sci. 1997 May; 110 (Pt 10): 1199-213. Le Cabec V., er al., "Differential expression of two forms of annexin 3 in human, neutrophils and monocytes and along their differentiation." Biochem Biophys Res Commun. 1992 Dec 30; 189(3):1471-6. Madoz-Gúrpide J., et al., "Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis." Mol Cell Proteomics. 2006 Aug; 5(8): 1471-83. Epub 2006 May 29. *

Also Published As

Publication number Publication date
US8012697B2 (en) 2011-09-06
EP2024748A2 (en) 2009-02-18
KR20090023372A (ko) 2009-03-04
AU2007256377B2 (en) 2012-11-01
WO2007141043A2 (en) 2007-12-13
RU2008152009A (ru) 2010-07-20
ES2396730T3 (es) 2013-02-25
AU2007256377A1 (en) 2007-12-13
CA2654330A1 (en) 2007-12-13
JP2009540278A (ja) 2009-11-19
DE07725949T1 (de) 2009-07-02
EP2024748B1 (en) 2012-12-12
DK2024748T3 (da) 2013-03-18
WO2007141043A3 (en) 2008-03-20
PL2024748T3 (pl) 2013-05-31
PT2024748E (pt) 2013-01-16
US20100233160A1 (en) 2010-09-16

Similar Documents

Publication Publication Date Title
CN101473041B (zh) He4与其它生化标记物在评估子宫内膜癌和子宫癌中的应用
CN106706914B (zh) 用于诊断上皮源性癌症的血液标志物及单克隆抗体
RU2467335C2 (ru) Моноклональные антитела против аннексина а3 для обнаружения карциномы простаты
AU2005231081A1 (en) RM2 antigen (beta1,4-GaINAc-disialyl-Lc4) as prostate cancer-associated antigen
JP2012524521A (ja) グリコデリンモノクローナル抗体および卵巣癌の検出におけるその使用のための方法
CN108700586A (zh) 用于评估癌症发生的风险的组合物和方法
Jiang et al. Peptide mimic isolated by autoantibody reveals human arrest defective 1 overexpression is associated with poor prognosis for colon cancer patients
CA2682132C (en) Use of he4 for assessment of breast cancers
AU2009295842A1 (en) Novel antibodies recognizing native annexin A3
WO2021246153A1 (ja) 膵臓がんの検出方法及び検出試薬
CN101501501A (zh) 用于检测前列腺癌的抗膜联蛋白a3单克隆抗体
CA3009768C (en) Compositions and methods for assessing the risk of cancer occurrence
HK1225411B (en) Use of he4 and other biochemical markers for assessment of ovarian cancers
HK1225411A (en) Use of he4 and other biochemical markers for assessment of ovarian cancers
HK1225411A1 (en) Use of he4 and other biochemical markers for assessment of ovarian cancers
HK1133445B (en) Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers
HK1136630B (en) Use of he4 for assessment of breast cancers
HK1219514B (en) Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers
HK1133445A (en) Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130612